Compounds of the following structure are described: wherein R.sub.1-R.sub.6, m, V, X, Y, Z and Q are described herein, or a pharmaceutically acceptable salt, tautomer, metabolite or prodrug thereof. These compounds are useful for treating a variety of hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake or synchronizing estrus.

 
Web www.patentalert.com

< Method of manufacturing a food container

> Oxazolidone derivatives as PR modulators

~ 00413